Holen Sie sich die Stockscreener-App
7.53
7.67%
0.5366
Schlusskurs vom Vortag:
$6.9934
Offen:
$7.1692
24-Stunden-Volumen:
52,124
Relative Volume:
1.99
Marktkapitalisierung:
$4.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.06M
KGV:
-0.1065
EPS:
-70.7173
Netto-Cashflow:
$-14.18M
1W Leistung:
+13.06%
1M Leistung:
+16.02%
6M Leistung:
-35.97%
1J Leistung:
-88.51%
1-Tages-Spanne:
$7.1692
$8.10
1-Wochen-Bereich:
$6.285
$8.10
52-Wochen-Spanne:
$4.93
$114.00
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Firmenname
Cns Pharmaceuticals Inc
Sektor
Branche
Telefon
1-800-946-9185
Adresse
2100 WEST LOOP SOUTH, HOUSTON
Vergleichen Sie CNSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
7.53 | 4.34M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Eingeleitet | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast - Digital Journal
CNS Pharmaceuticals CEO Outlines Strategy to Target Glioblastoma by Overcoming Blood-Brain Barrier - citybuzz
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics ... - Enidnews.com
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewswire
Will CNS Pharmaceuticals Inc. stock gain from lower inflationGold Moves & High Accuracy Trade Alerts - Newser
CNS Pharma (CNSP) Stock Analysis Report | Financials & Insights - Benzinga
Acumen and JCR Advance Next-Generation CNS Therapeutics with EBD™ Technology - citybiz
CNS Pharmaceuticals, Inc. (CNSP) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
What analysts say about CNS Pharmaceuticals Inc stockGrowth vs. Value Investing & High Profit Investment Ideas - earlytimes.in
Where Analysts See Bemco Hydraulics Limited Stock by YearEndRisk-Reward Ratio Analysis & Free Rapid Return Acceleration - earlytimes.in
Bank of America CNS Therapeutics Virtual Conference - marketscreener.com
CNS Pharmaceuticals, Inc.Common Stock (NQ: CNSP - Markets Financial Content
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times
CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com Australia
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting By Investing.com - Investing.com South Africa
CNSP shareholders approve major share increase and equity plan changes - Stock Titan
How strong is CNS Pharmaceuticals Inc. stock revenue growthWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
How CNS Pharmaceuticals Inc. stock responds to policy changesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Can CNS Pharmaceuticals Inc. stock outperform in 2025 bull marketAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock gaining market shareJuly 2025 Review & AI Optimized Trade Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
[Form 4] CNS Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Trend analysis for CNS Pharmaceuticals Inc. this weekJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com
Will CNS Pharmaceuticals Inc. stock deliver better than expected guidance2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - MSN
Full technical analysis of CNS Pharmaceuticals Inc. stockJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Will CNS Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Why CNS Pharmaceuticals Inc. stock remains resilientMarket Growth Summary & Verified Entry Point Detection - newser.com
CNS Pharmaceuticals Form 4 details 4,881-share option grant - Stock Titan
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):